Company intelligence
GenomeWeb
An independent news organization covering genetics, genomics, and molecular diagnostics.
About GenomeWeb
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market. GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, information technology, and molecular diagnostics. GenomeWeb is a business unit of Crain Communications.
Verified activity
Signals from GenomeWeb
11 published signals
Research & Knowledge
GenomeWeb disclosed the first clinical efficacy results on a Lp(a)-targeted drug.
Reported by GenomeWeb
Legal & Regulatory
GenomeWeb notes that the appeals court disagreed that the program for Casgevy patients on Medicaid would also run afoul of the Beneficiary Inducement Statute.
Reported by GenomeWeb
Partnerships
GenomeWeb announced that Bluejay's system will create a pathway for commercial expansion if it receives FDA clearance or approval and is launched in the US.
Reported by GenomeWeb
Research & Knowledge
GenomeWeb announced that the FACTS-3D project will use Cubase's 3D spatial tools to profile HeartBeat's human cardiac organoids.
Reported by GenomeWeb
Strategy & Corporate Development
GenomeWeb notes that Labcorp's central lab and clinical trial services business has grown by acquiring Central Lab Services Provider.
Reported by GenomeWeb
Legal & Regulatory
GenomeWeb obtained a certificate under the EU's In Vitro Diagnostics Regulation to allow Cambridge, UK-based company to offer its test across the region.
Reported by GenomeWeb
Legal & Regulatory
GenomeWeb announced that the antisense oligonucleotide is the first approved drug for Alexander disease
Reported by GenomeWeb
Products & Services
GenomeWeb launched an FDA Precision Medicine Drug Approval Tracker to provide real-time updates on FDA approvals of precision medicine therapies.
Reported by Turna Ray
Products & Services
GenomeWeb launched a new website with one login for users to access journalism, newsletters, and content from GenomeWeb, 360Dx, and Precision Medicine Online.
Reported by Turna Ray
Products & Services
GenomeWeb launched a new newsletter under the GenomeWeb brand to deliver focused coverage of topics you follow.
Reported by Turna Ray
Research & Knowledge
GenomeWeb published a case involving a 10-year-old girl with bilateral vestibular schwannomas who had a negative comprehensive genetic test ordered from a high-volume lab, with no mention of an NF2 variant.
Reported by Turna Ray